Europe Opioids Drugs Market Report 2016
- QYR753293
- 106 Pages
- November 2016
- Pharmaceuticals
Sales, means the sales volume of Opioids Drugs
Revenue, means the sales value of Opioids Drugs
This report studies sales (consumption) of Opioids Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Sanofi-aventis US LLC
Johnson & Johnson
Teva pharmaceuticals
Purdue Pharma
Pfizer
Orexo Pharmaceuticals
Endo Pharmaceuticals
AbbVie
Allergan
Hospira
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Opioids Drugs in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Hydrocodone (e.g., Vicodin)
Codeine
Oxycodone (e.g., OxyContin, Percocet)
Morphine (e.g., Kadian, Avinza)
Others
Split by application, this report focuses on sales, market share and growth rate of Opioids Drugs in each application, can be divided into
Neuropathic pain treatment
Orthopedic pain treatment
Other pain treatment
Europe Opioids Drugs Market Report 2016
1 Opioids Drugs Overview
1.1 Product Overview and Scope of Opioids Drugs
1.2 Classification of Opioids Drugs
1.2.1 Hydrocodone (e.g., Vicodin)
1.2.2 Codeine
1.2.3 Oxycodone (e.g., OxyContin, Percocet)
1.2.4 Morphine (e.g., Kadian, Avinza)
1.2.5 Others
1.3 Application of Opioids Drugs
1.3.1 Neuropathic pain treatment
1.3.2 Orthopedic pain treatment
1.3.3 Other pain treatment
1.4 Opioids Drugs Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Opioids Drugs (2011-2021)
1.5.1 Europe Opioids Drugs Sales and Growth Rate (2011-2021)
1.5.2 Europe Opioids Drugs Revenue and Growth Rate (2011-2021)
2 Europe Opioids Drugs by Manufacturers, Type and Application
2.1 Europe Opioids Drugs Market Competition by Manufacturers
2.1.1 Europe Opioids Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Opioids Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Opioids Drugs (Volume and Value) by Type
2.2.1 Europe Opioids Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Europe Opioids Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Opioids Drugs (Volume and Value) by Countries
2.3.1 Europe Opioids Drugs Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Opioids Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Opioids Drugs (Volume) by Application
3 Germany Opioids Drugs (Volume, Value and Sales Price)
3.1 Germany Opioids Drugs Sales and Value (2011-2016)
3.1.1 Germany Opioids Drugs Sales and Growth Rate (2011-2016)
3.1.2 Germany Opioids Drugs Revenue and Growth Rate (2011-2016)
3.1.3 Germany Opioids Drugs Sales Price Trend (2011-2016)
3.2 Germany Opioids Drugs Sales and Market Share by Manufacturers
3.3 Germany Opioids Drugs Sales and Market Share by Type
3.4 Germany Opioids Drugs Sales and Market Share by Application
4 France Opioids Drugs (Volume, Value and Sales Price)
4.1 France Opioids Drugs Sales and Value (2011-2016)
4.1.1 France Opioids Drugs Sales and Growth Rate (2011-2016)
4.1.2 France Opioids Drugs Revenue and Growth Rate (2011-2016)
4.1.4 France Opioids Drugs Sales Price Trend (2011-2016)
4.2 France Opioids Drugs Sales and Market Share by Manufacturers
4.3 France Opioids Drugs Sales and Market Share by Type
4.4 France Opioids Drugs Sales and Market Share by Application
5 UK Opioids Drugs (Volume, Value and Sales Price)
5.1 UK Opioids Drugs Sales and Value (2011-2016)
5.1.1 UK Opioids Drugs Sales and Growth Rate (2011-2016)
5.1.2 UK Opioids Drugs Revenue and Growth Rate (2011-2016)
5.1.5 UK Opioids Drugs Sales Price Trend (2011-2016)
5.2 UK Opioids Drugs Sales and Market Share by Manufacturers
5.3 UK Opioids Drugs Sales and Market Share by Type
5.4 UK Opioids Drugs Sales and Market Share by Application
6 Russia Opioids Drugs (Volume, Value and Sales Price)
6.1 Russia Opioids Drugs Sales and Value (2011-2016)
6.1.1 Russia Opioids Drugs Sales and Growth Rate (2011-2016)
6.1.2 Russia Opioids Drugs Revenue and Growth Rate (2011-2016)
6.1.6 Russia Opioids Drugs Sales Price Trend (2011-2016)
6.2 Russia Opioids Drugs Sales and Market Share by Manufacturers
6.3 Russia Opioids Drugs Sales and Market Share by Type
6.4 Russia Opioids Drugs Sales and Market Share by Application
7 Italy Opioids Drugs (Volume, Value and Sales Price)
7.1 Italy Opioids Drugs Sales and Value (2011-2016)
7.1.1 Italy Opioids Drugs Sales and Growth Rate (2011-2016)
7.1.2 Italy Opioids Drugs Revenue and Growth Rate (2011-2016)
7.1.7 Italy Opioids Drugs Sales Price Trend (2011-2016)
7.2 Italy Opioids Drugs Sales and Market Share by Manufacturers
7.3 Italy Opioids Drugs Sales and Market Share by Type
7.4 Italy Opioids Drugs Sales and Market Share by Application
8 Spain Opioids Drugs (Volume, Value and Sales Price)
8.1 Spain Opioids Drugs Sales and Value (2011-2016)
8.1.1 Spain Opioids Drugs Sales and Growth Rate (2011-2016)
8.1.2 Spain Opioids Drugs Revenue and Growth Rate (2011-2016)
8.1.8 Spain Opioids Drugs Sales Price Trend (2011-2016)
8.2 Spain Opioids Drugs Sales and Market Share by Manufacturers
8.3 Spain Opioids Drugs Sales and Market Share by Type
8.4 Spain Opioids Drugs Sales and Market Share by Application
9 Benelux Opioids Drugs (Volume, Value and Sales Price)
9.1 Benelux Opioids Drugs Sales and Value (2011-2016)
9.1.1 Benelux Opioids Drugs Sales and Growth Rate (2011-2016)
9.1.2 Benelux Opioids Drugs Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Opioids Drugs Sales Price Trend (2011-2016)
9.2 Benelux Opioids Drugs Sales and Market Share by Manufacturers
9.3 Benelux Opioids Drugs Sales and Market Share by Type
9.4 Benelux Opioids Drugs Sales and Market Share by Application
10 Europe Opioids Drugs Manufacturers Analysis
10.1 Sanofi-aventis US LLC
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Opioids Drugs Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Sanofi-aventis US LLC Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Opioids Drugs Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Johnson & Johnson Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Teva pharmaceuticals
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Opioids Drugs Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Teva pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Purdue Pharma
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Opioids Drugs Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Purdue Pharma Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Pfizer
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Opioids Drugs Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Pfizer Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Orexo Pharmaceuticals
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Opioids Drugs Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Orexo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Endo Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Opioids Drugs Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Endo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 AbbVie
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Opioids Drugs Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 AbbVie Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Allergan
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Opioids Drugs Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Allergan Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Hospira
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioids Drugs Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Hospira Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Opioids Drugs Manufacturing Cost Analysis
11.1 Opioids Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Opioids Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Opioids Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Opioids Drugs Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Opioids Drugs Market Forecast (2016-2021)
14.1 Germany Opioids Drugs Sales Forecast (2016-2021)
14.2 France Opioids Drugs Sales Forecast (2016-2021)
14.3 UK Opioids Drugs Sales Forecast (2016-2021)
14.4 Russia Opioids Drugs Sales Forecast (2016-2021)
14.5 Italy Opioids Drugs Sales Forecast (2016-2021)
14.6 Spain Opioids Drugs Sales Forecast (2016-2021)
14.7 Benelux Opioids Drugs Sales Forecast (2016-2021)
14.8 Europe Opioids Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Opioids Drugs Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Opioids Drugs
Table Classification of Opioids Drugs
Figure Europe Sales Market Share of Opioids Drugs by Type in 2015
Figure Hydrocodone (e.g., Vicodin) Picture
Figure Codeine Picture
Figure Oxycodone (e.g., OxyContin, Percocet) Picture
Figure Morphine (e.g., Kadian, Avinza) Picture
Figure Others Picture
Table Application of Opioids Drugs
Figure Europe Sales Market Share of Opioids Drugs by Application in 2015
Figure Neuropathic pain treatment Examples
Figure Orthopedic pain treatment Examples
Figure Other pain treatment Examples
Figure Germany Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure France Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure UK Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Opioids Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Opioids Drugs Sales and Growth Rate (2011-2021)
Figure Europe Opioids Drugs Revenue and Growth Rate (2011-2021)
Table Europe Opioids Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Opioids Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Opioids Drugs Sales Share by Manufacturers
Figure 2016 Opioids Drugs Sales Share by Manufacturers
Table Europe Opioids Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Opioids Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Opioids Drugs Revenue Share by Manufacturers
Table 2016 Europe Opioids Drugs Revenue Share by Manufacturers
Table Europe Opioids Drugs Sales and Market Share by Type (2011-2016)
Table Europe Opioids Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Opioids Drugs by Type (2011-2016)
Figure Europe Opioids Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Opioids Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Opioids Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Opioids Drugs by Type (2011-2016)
Figure Europe Opioids Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Opioids Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Opioids Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Opioids Drugs by Countries (2011-2016)
Table Europe Opioids Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Opioids Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Opioids Drugs by Countries (2011-2016)
Table Europe Opioids Drugs Sales and Market Share by Application (2011-2016)
Table Europe Opioids Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Opioids Drugs by Application (2011-2016)
Figure Germany Opioids Drugs Sales and Growth Rate (2011-2016)
Figure Germany Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Opioids Drugs Sales Price Trend (2011-2016)
Table Germany Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Opioids Drugs Sales by Type (2015 and 2016)
Table Germany Opioids Drugs Market Share by Type (2015 and 2016)
Table Germany Opioids Drugs Sales by Application (2015 and 2016)
Table Germany Opioids Drugs Market Share by Application (2015 and 2016)
Figure France Opioids Drugs Sales and Growth Rate (2011-2016)
Figure France Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure France Opioids Drugs Sales Price Trend (2011-2016)
Table France Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table France Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table France Opioids Drugs Sales by Type (2015 and 2016)
Table France Opioids Drugs Market Share by Type (2015 and 2016)
Table France Opioids Drugs Sales by Application (2015 and 2016)
Table France Opioids Drugs Market Share by Application (2015 and 2016)
Figure UK Opioids Drugs Sales and Growth Rate (2011-2016)
Figure UK Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure UK Opioids Drugs Sales Price Trend (2011-2016)
Table UK Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table UK Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Opioids Drugs Sales by Type (2015 and 2016)
Table UK Opioids Drugs Market Share by Type (2015 and 2016)
Table UK Opioids Drugs Sales by Application (2015 and 2016)
Table UK Opioids Drugs Market Share by Application (2015 and 2016)
Figure Russia Opioids Drugs Sales and Growth Rate (2011-2016)
Figure Russia Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Opioids Drugs Sales Price Trend (2011-2016)
Table Russia Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Opioids Drugs Sales by Type (2015 and 2016)
Table Russia Opioids Drugs Market Share by Type (2015 and 2016)
Table Russia Opioids Drugs Sales by Application (2015 and 2016)
Table Russia Opioids Drugs Market Share by Application (2015 and 2016)
Figure Italy Opioids Drugs Sales and Growth Rate (2011-2016)
Figure Italy Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Opioids Drugs Sales Price Trend (2011-2016)
Table Italy Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Opioids Drugs Sales by Type (2015 and 2016)
Table Italy Opioids Drugs Market Share by Type (2015 and 2016)
Table Italy Opioids Drugs Sales by Application (2015 and 2016)
Table Italy Opioids Drugs Market Share by Application (2015 and 2016)
Figure Spain Opioids Drugs Sales and Growth Rate (2011-2016)
Figure Spain Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Opioids Drugs Sales Price Trend (2011-2016)
Table Spain Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Opioids Drugs Sales by Type (2015 and 2016)
Table Spain Opioids Drugs Market Share by Type (2015 and 2016)
Table Spain Opioids Drugs Sales by Application (2015 and 2016)
Table Spain Opioids Drugs Market Share by Application (2015 and 2016)
Figure Benelux Opioids Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Opioids Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Opioids Drugs Sales Price Trend (2011-2016)
Table Benelux Opioids Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Opioids Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Opioids Drugs Sales by Type (2015 and 2016)
Table Benelux Opioids Drugs Market Share by Type (2015 and 2016)
Table Benelux Opioids Drugs Sales by Application (2015 and 2016)
Table Benelux Opioids Drugs Market Share by Application (2015 and 2016)
Table Opioids Drugs Basic Information List
Table Sanofi-aventis US LLC Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-aventis US LLC Opioids Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Opioids Drugs Sales Market Share (2011-2016)
Table Teva pharmaceuticals Basic Information List
Table Teva pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva pharmaceuticals Opioids Drugs Sales Market Share (2011-2016)
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Purdue Pharma Opioids Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Opioids Drugs Sales Market Share (2011-2016)
Table Orexo Pharmaceuticals Basic Information List
Table Orexo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexo Pharmaceuticals Opioids Drugs Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Opioids Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Opioids Drugs Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Opioids Drugs Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Opioids Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Opioids Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Drugs
Figure Manufacturing Process Analysis of Opioids Drugs
Figure Opioids Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioids Drugs Major Manufacturers in 2015
Table Major Buyers of Opioids Drugs
Table Distributors/Traders List
Figure Germany Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Opioids Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Opioids Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Opioids Drugs Sales Forecast by Type (2016-2021)
Table Europe Opioids Drugs Sales Forecast by Application (2016-2021)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
